| P50 | author | Etienne Levavasseur | Q66360620 |
| | Philippe Hantraye | Q67207772 |
| P2093 | author name string | Armand Perret-Liaudet | |
| | Nathalie Streichenberger | |
| | Marc Eloit | |
| | Vincent Lebon | |
| | Stéphane Haïk | |
| | Jean-Philippe Deslys | |
| | Olivier Andreoletti | |
| | Chryslain Sumian | |
| | Jacqueline Mikol | |
| | Emmanuel E Comoy | |
| | Nina Jaffré | |
| P2860 | cites work | Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers | Q22251089 |
| | Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey | Q24606150 |
| | Natural history and clinical features of the flail arm and flail leg ALS variants | Q24647753 |
| | A novel human disease with abnormal prion protein sensitive to protease | Q24648865 |
| | Evaluation of quinacrine treatment for prion diseases | Q24682427 |
| | De novo generation of infectious prions in vitro produces a new disease phenotype | Q27317045 |
| | A general model of prion strains and their pathogenicity | Q28256770 |
| | Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate | Q28473442 |
| | Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity | Q28534974 |
| | Preclinical detection of variant CJD and BSE prions in blood | Q30436588 |
| | Rapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity? | Q30446918 |
| | Rapid and discriminatory diagnosis of scrapie and BSE in retro-pharyngeal lymph nodes of sheep | Q33246296 |
| | Molecular distinction between pathogenic and infectious properties of the prion protein | Q33338476 |
| | Enhanced neuroinvasion by smaller, soluble prions | Q33588967 |
| | Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays | Q33769767 |
| | Progressive necrotic myelopathy: clinical course in 9 patients | Q33861433 |
| | Kuru in the 21st century--an acquired human prion disease with very long incubation periods | Q33997105 |
| | Biochemistry. What makes a prion infectious? | Q34100700 |
| | Unconventional Viruses and the Origin and Disappearance of Kuru | Q34258483 |
| | Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health | Q35057650 |
| | Estimation of the exposure of the UK population to the bovine spongiform encephalopathy agent through dietary intake during the period 1980 to 1996. | Q35148934 |
| | Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease | Q35448997 |
| | Bovine spongiform encephalopathy (BSE) and its epidemiology | Q35549007 |
| | Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood. | Q50789460 |
| | Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. | Q51037854 |
| | BSE transmission to macaques | Q59098670 |
| | Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein | Q71970964 |
| | Innate immunity mediates follicular transport of particulate but not soluble protein antigen | Q83684751 |
| | Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions | Q35585904 |
| | Iatrogenic Creutzfeldt-Jakob disease, final assessment | Q35979990 |
| | Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type | Q36607110 |
| | Neuromyelitis optica - Devic's syndrome, update | Q36617526 |
| | Dissociation between transmissible spongiform encephalopathy (TSE) infectivity and proteinase K-resistant PrP(Sc) levels in peripheral tissue from a murine transgenic model of TSE disease. | Q36827461 |
| | Asynchronous onset of clinical disease in BSE-infected macaques | Q37021022 |
| | Rodent models for prion diseases | Q37088655 |
| | An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products | Q37307945 |
| | De novo generation of infectious prions with bacterially expressed recombinant prion protein | Q37327452 |
| | A novel prion disease associated with diarrhea and autonomic neuropathy | Q37393739 |
| | Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease | Q37449009 |
| | New generation QuIC assays for prion seeding activity | Q37993987 |
| | Evaluation of the protection of primates transfused with variant Creutzfeldt-Jakob disease-infected blood products filtered with prion removal devices: a 5-year update | Q38388077 |
| | Pathogenic factors underlying the lesions in Leigh's disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences | Q38482246 |
| | Leigh syndrome: neuropathology and pathogenesis. | Q38482925 |
| | Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK Transfusion Medicine Epidemiology Review Study | Q38680982 |
| | The prion protein is critical for DNA repair and cell survival after genotoxic stress | Q38925522 |
| | Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. | Q40477337 |
| | Foodborne transmission of bovine spongiform encephalopathy to nonhuman primates | Q40506456 |
| | Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis | Q42912800 |
| | Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia | Q43195687 |
| | Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent | Q44592404 |
| | Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy | Q44949376 |
| | Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease | Q48126727 |
| | Neuronal apoptosis in Creutzfeldt-Jakob disease | Q48226834 |
| | Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice | Q48290293 |
| | Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity | Q48303980 |
| | Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129. | Q48351479 |
| | Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology | Q48408133 |
| | Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation | Q48595468 |
| | B(0) homogeneity throughout the monkey brain is strongly improved in the sphinx position as compared to the supine position. | Q48663843 |
| | Risk of oral infection with bovine spongiform encephalopathy agent in primates | Q49016765 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prion protein family | Q24724413 |
| P304 | page(s) | 1268 | |
| P577 | publication date | 2017-11-02 | |
| P1433 | published in | Nature Communications | Q573880 |
| P1476 | title | Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and macaque | |
| P478 | volume | 8 | |